NCT05414136View on ClinicalTrials.gov

Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

June 17, 2024

Study Completion Date

June 17, 2024

Conditions
Advanced Solid Tumor
Interventions
DRUG

BAT1006

Intravenous fluids

Trial Locations (2)

510060

Sun Yat-sen University Cancer Center, Guangzhou

Unknown

Henan Cancer Hospital, Zhengzhou

Sponsors
All Listed Sponsors
lead

Bio-Thera Solutions

INDUSTRY